Bile Acid Diarrhea Diagnosis and Treatment

Clinical Presentation and Diagnosis

Bile acid diarrhea presents with chronic, watery diarrhea that occurs after meals and usually responds to fasting, making the postprandial timing a key diagnostic clue, according to the European Society of Gastrointestinal Endoscopy 1, 2.
The mechanism involves unabsorbed bile acids reaching the colon where they stimulate fluid, mucus, and sodium secretion while increasing gastrointestinal motility and stimulating defecation, as stated by the American Gastroenterological Association 3.

High-risk patients who should be tested for bile acid diarrhea include those with terminal ileal resection, where over 80% develop bile acid diarrhea, as recommended by the British Society of Gastroenterology 4, 5.
Patients who have undergone cholecystectomy are also at risk, with up to 10% developing chronic diarrhea through bile acid malabsorption, according to the American College of Gastroenterology 1, 6.

The American College of Gastroenterology recommends cholestyramine as the first-line treatment for bile acid diarrhea, starting at 4 g once or twice daily with meals, then titrating to 2-12 g/day based on symptom response, with a clinical response achieved in approximately 70% of patients overall 7.
Alternative bile acid sequestrants include colesevelam or colestipol for patients who cannot tolerate cholestyramine, as suggested by the European Society of Gastrointestinal Endoscopy 4, 5.

The Canadian Association of Gastroenterology recommends diagnostic testing with SeHCAT or serum 7α-hydroxy-4-cholesten-3-one (C4) is preferred over empiric treatment in high-risk patients, with a therapeutic trial of bile acid sequestrants appropriate when testing is unavailable 7, 4, 5.

91-100% of patients with terminal ileal resection for Crohn's disease demonstrate abnormal SeHCAT retention (<15%), indicating at least mild bile acid malabsorption, according to the American Gastroenterological Association 8
87-92% of patients have severe malabsorption (SeHCAT retention <10%) 8
76-82% of patients with terminal ileal resection for reasons other than Crohn's disease develop bile acid diarrhea 8

The terminal ileum contains the apical Na+-dependent bile salt transporter responsible for reabsorbing over 90% of bile acids, as noted by the European Association for the Study of the Liver 9

Diagnostic testing may not be necessary before initiating treatment in patients with documented terminal ileal resection, given the extremely high pretest probability, according to the Canadian Association of Gastroenterology 8
The Canadian Association of Gastroenterology recommends that in patients with ileal resection, there is an extremely high risk of bile acid diarrhea, and diagnostic testing may not be necessary before treatment 8

In cases of extensive ileal resection (>100 cm), the primary problem shifts from bile acid diarrhea to fat malabsorption, as noted by the European Society for Clinical Nutrition and Metabolism 10

Patients with extensive loss of terminal ileal function develop bile acid diarrhea and may progress to fat malabsorption, but the depleted bile acid pool does not make bile more lithogenic; instead, cholesterol saturation in bile is reduced, so the risk of cholesterol gallstone formation is not increased. This distinction is emphasized to avoid inappropriate treatment strategies aimed at preventing gallstones. 11